Detalhe da pesquisa
1.
Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial.
Diabetes Obes Metab
; 25(11): 3347-3355, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37580972
2.
Comparing a daily versus weekly titration algorithm in people with type 2 diabetes switching from basal insulin to iGlarLixi in the LixiLan ONE CAN randomized trial.
Diabetes Obes Metab
; 24(10): 1998-2007, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35670659
3.
Metformin and carotid intima-media thickness in never-smokers with type 1 diabetes: The REMOVAL trial.
Diabetes Obes Metab
; 23(6): 1371-1378, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33591613
4.
Switching between GLP-1 receptor agonists in clinical practice: Expert consensus and practical guidance.
Int J Clin Pract
; 75(2): e13731, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-32975890
5.
Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial.
Am J Gastroenterol
; 115(7): 1055-1065, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32618656
6.
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial.
Cardiovasc Diabetol
; 18(1): 73, 2019 06 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31167654
7.
Sodium-glucose co-transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: The STOP DKA Protocol.
Diabetes Obes Metab
; 21(10): 2192-2202, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31183975
8.
GREATER COMBINED REDUCTIONS IN HbA1C ≥1.0% AND WEIGHT ≥5.0% WITH SEMAGLUTIDE VERSUS COMPARATORS IN TYPE 2 DIABETES.
Endocr Pract
; 25(6): 589-597, 2019 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-30865526
9.
Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS.
Diabetes Obes Metab
; 20(10): 2379-2388, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29923323
10.
Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial.
Diabetes Obes Metab
; 19(4): 509-516, 2017 04.
Artigo
Inglês
| MEDLINE | ID: mdl-27935183
11.
In-home nighttime predictive low glucose suspend experience in children and adults with type 1 diabetes.
Pediatr Diabetes
; 18(5): 332-339, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27125223
12.
Ketone production in children with type 1 diabetes, ages 4-14 years, with and without nocturnal insulin pump suspension.
Pediatr Diabetes
; 18(6): 422-427, 2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-27402452
13.
Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial.
Diabetologia
; 57(10): 2030-7, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-24985147
14.
Multicentre randomized controlled trial of structured transition on diabetes care management compared to standard diabetes care in adolescents and young adults with type 1 diabetes (Transition Trial).
BMC Pediatr
; 13: 163, 2013 Oct 09.
Artigo
Inglês
| MEDLINE | ID: mdl-24106787
15.
Effectiveness of Nonmydriatic Ultra-Widefield Retinal Imaging to Screen for Diabetic Eye Disease: A Randomized Controlled Trial (Clearsight).
Diabetes Care
; 46(2): 399-407, 2023 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36469332
16.
Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers.
Diabetes Ther
; 14(2): 377-386, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36574199
17.
Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.
Kidney Int
; 81(6): 586-94, 2012 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-22166848
18.
Remission of Type 2 Diabetes Following a Short-term Intensive Intervention With Insulin Glargine, Sitagliptin, and Metformin: Results of an Open-label Randomized Parallel-Design Trial.
Diabetes Care
; 45(1): 178-185, 2022 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34728531
19.
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
Lancet
; 376(9739): 419-30, 2010 Aug 07.
Artigo
Inglês
| MEDLINE | ID: mdl-20594588
20.
Remission of Type 2 Diabetes Following a Short-term Intervention With Insulin Glargine, Metformin, and Dapagliflozin.
J Clin Endocrinol Metab
; 105(8)2020 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32403130